relative cd107a degranulation activity further confirmed that blocking the pd-1/pd-l1 pathway led to full functional recovery in the supraphysiological t cells (figure 5 e).
Our data revealed preferential expression of PD-1 in supraphysiological CD8 + T cells, i.e., those with TCRs in the nanomolar range (wtc51m).